Pcsa stock.

Trade PCSA with: Price/Earnings ttm 0.00. Earnings Per Share ttm -7.44. Most Recent Earnings $-0.24 on 03/29/24. Latest Earnings Date 05/20/24. Annual Dividend & Yield …Processa Pharmaceuticals, Inc. (US:PCSA) has 13 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 112,706 shares. PCS Share Price: Find the latest news on PCS Stock Price. Get all the information on PCS with historic price charts for NSE / BSE. Experts & Broker view also get the PCS Ltd. buy/sell tips ... Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) has announced a public offering of 1,555,555 shares of common stock and common warrants, with a combined public offering price of $4.50 per share. The gross proceeds from the offering are expected to be $7.0 million. The common warrants will have an exercise price of $4.50 per share …About MetroPCS Communications Stock (NYSE:PCS) T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

Processa Pharmaceuticals Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology …

PCSA Stock Price. -82.28% May 2024 Mar 2024 Jan 2024 Nov 2023 Sep 2023 Jul 2023 0 5 10 15 20. 52 Week Range. 1.40 18.00. Day Range. 2.08 2.19. EPS (FWD) -3.82. PE. - Div Rate. - Yield. - Market... Find the latest SEC Filings data for Processa Pharmaceuticals, Inc. Common Stock (PCSA) at Nasdaq.com.

The average trading volume of PCSA on May 16, 2024 was 1.48M shares. PCSA) stock’s latest price update. Processa Pharmaceuticals Inc (NASDAQ: PCSA)’s stock price has plunge by -7.34relation to previous closing price of 2.18. Nevertheless, the company has seen a -18.55% plunge in its stock price over the last five trading sessions.4 days ago · PCSA is the ticker symbol for Processa Pharmaceuticals Inc., a biotech company developing treatments for neurodegenerative diseases. The stock price, news, analyst ratings, financials and other data are available on MarketWatch. Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules. (GlobeNewswire) Jan-04-23 08:30AM. Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023. Processa Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing the chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing ...

Jax to ewr

Processa Pharmaceuticals Inc. is a development-stage pharmaceutical company that uses a unique approach to develop not discover drugs that help in the treatment of oncology and other high unmet medical need diseases with unparalleled regulatory science and clinical expertise. Our drug candidates are intended for patients who have limited ...

What's Happening With PCSA Stock Today? Processa Pharmaceuticals Inc (PCSA) stock is unchanged 0% while the S&P 500 has risen 0.7% as of 4:00 PM on Friday, Oct 13. PCSA is unchanged $0.00 from the previous closing price of $0.48 on volume of 19,953,405 shares. Over the past year the S&P 500 has risen 18.49% while PCSA has fallen -76.24%.Stock Price Statistics The stock price has decreased by -83.46% in the last 52 weeks. The beta is 0.53, so PCSA's price volatility has been lower than the market average.Co-Founder recently bought US$51k worth of stock Feb 10. Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule Feb 07. Processa Pharmaceuticals, Inc. has completed a Follow-on Equity Offering in the amount of $6.99989 million. ... PCSA) Cash Burn Rate Jan 20. Processa Pharmaceuticals …Processa Pharmaceuticals, Inc. announces plans to expand the development of NGC-Cap into the treatment of advanced or metastatic breast cancer. The FDA agrees that existing data and studies can be used to support the Phase 2 breast cancer trial design, making the development a more efficient and straightforward path to approval. The …Oct 7, 2020 · Potential Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) shareholders may wish to note that the Co-Founder, Patrick Lin, recently bought US$125k worth of stock, paying US$4.00 for each share.While ... HANOVER, MD, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that Dr. David Young ...

A high-level overview of Processa Pharmaceuticals, Inc. (PCSA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Bluberries. Pharmaceutical company Processa Pharmaceuticals (NASDAQ:PCSA) said on Thursday that it is set to effect a 1-for-20 reverse stock split to regain compliance with Nasdaq rule.The share ...Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.PCSA - Processa Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. ... Processa Pharmaceuticals stock price target cut to $2 from $5 at Maxim Group MarketWatch. Thursday, January 12, 2023. 07:38 AM ET. Processa Pharmaceuticals stock price …2 in Stock, despatched same dayAdditional quantity lead time 9 days. Product Details. This holder is ideal for supporting and clamping printed circuit boards ...4 days ago · Processa Pharma (NASDAQ: PCSA) just reported results for the first quarter of 2024. Processa Pharma reported earnings per share of -$1.11. The company did not report any revenue for the quarter ...

You can buy or sell PCSA and other ETFs, options, and stocks. View the real-time PCSA price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd ...

PCS Share Price: Find the latest news on PCS Stock Price. Get all the information on PCS with historic price charts for NSE / BSE. Experts & Broker view also get the PCS Ltd. buy/sell tips ...Apr 25, 2024 ... The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.25 A.M. ET). In the Green. View the latest Processa Pharmaceuticals Inc. (PCSA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.Processa Pharmaceuticals' stock was trading at $6.6920 at the start of the year. Since then, PCSA shares have decreased by 68.8% and is now trading at $2.09. The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.May 6, 2024 · Rhea-AI Summary. Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) has closed a public offering of 1,555,555 shares of common stock and common warrants, raising $7.0 million in gross proceeds. The offering price per share was $4.50, with the common warrants having an exercise price of $4.50 per share and a term of five years. Interactive stock price chart for Processa Pharmaceuticals, Inc. (PCSA) with real-time updates, full price history, technical analysis and more.

Timer stopwatch

Get the latest stock price, quote, news and history of PCSA, a biotechnology company developing drugs for neurodegenerative diseases. See key data, market cap, data …

What is Processa Pharmaceuticals's stock symbol? The ticker symbol for Processa Pharmaceuticals is PCSA. What is the current stock price of Processa ...Insiders have been net buyers of 5.4% shares of the company over the past six months. However, the stock is seeing signs of weakness, as it is currently trading below its 50-day and 200-day moving averages of $0.61 and $1.84, respectively. This article provides insight into the metrics that are reflective of the current challenges the company ... See Processa Pharmaceuticals, Inc. (PCSA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 10/13/2023 - 01:08 PM . HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces …May 16, 2024 1:36 AM ET Adial Pharmaceuticals, Inc. (ADIL) Stock By: Meghavi Singh, SA News Editor. Adial Pharmaceuticals press release ( NASDAQ: ADIL ): Q1 net …Processa Pharmaceuticals Stock Forecast, PCSA stock price prediction. Price target in 14 days: 2.886 USD. The best long-term & short-term Processa ...Insider Buyers At Processa Pharmaceuticals Recover Some Losses, But Still Down US$40k. Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and …Rhea-AI Summary. Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) has closed a public offering of 1,555,555 shares of common stock and common warrants, raising $7.0 million in gross proceeds. The offering price per share was $4.50, with the common warrants having an exercise price of $4.50 per share and a term of five years. Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules. (GlobeNewswire) Jan-04-23 08:30AM. Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023. PCSA Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Processa Pharmaceuticals, Inc. PCSA stock quote prices, financial information, real-time forecasts, and company news ...Processa Pharmaceuticals, Inc. PCSANasdaq Stock Market. See on Supercharts. Overview. Financials News Ideas Technicals Forecast. PCSA chart. 1 day −1.88% 5 …What is the fair value of PCSA stock? Investors. use many financial metrics, analyses, models, and charts to gauge PCSA's fair value.Using relative valuations . metrics:PCSA; could be undervalued based on its P/B ratio of 1.39x, relative to Biotechnology industry P/B ratio of . 5.8xYou can access additional valuation analysis on …

See Processa Pharmaceuticals, Inc. (PCSA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.The pharmaceutical company revealed plans to offer 1,555,555 shares of its common stock, along with common warrants enabling the purchase of 1,555,555 units of common stock. The offering involves both the common stock and its accompanying warrants at a bundled price of $4.50 each. Dyadic International Inc. (NASDAQ: DYAI) …PCSA Stock Smart Score The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.Instagram:https://instagram. from english to italian Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.5.8400. 5.2000. 5.2400. 5.2400. 2,125. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for PCSA stock on Yahoo Finance. View daily, weekly or monthly formats back to when Processa Pharmaceuticals, Inc. stock was issued. boston to bangkok View today's Processa Pharmaceuticals Inc stock price and latest PCSA news and analysis. Create real-time notifications to follow any changes in the live stock price. air ticket from new york to los angeles At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Processa Pharmaceuticals stock analysis 2024. View PCSA current price, quote, financial & revenue summaries, forecast, earnings transcripts, and news. ... Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use. Company. About … a b c ya PCSA stock is up about 90% as of this writing, although shares climbed more than 150% at one point today. Undergirding sentiment are encouraging safety results regarding Processa’s anti-cancer ... goat simulator 3. Track Processa Pharmaceuticals Inc (PCSA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get … tracker tracing PCSA. 2.090. -1.88%. Webull offers Processa Pharmaceuticals Inc (PCSA) historical stock prices, in-depth market analysis, NASDAQ: PCSA real-time stock quote data, in-depth charts.Processa Pharmaceuticals (NASDAQ:PCSA) on Friday priced the public offering of its stock and warrants to raise gross proceeds of up to $7 million.The offering will consist of 1,555,555 shares or ... sacks off fifth Mountain. Loading Chart for PCSA. 9/21 12:03 PM. Previous Close 2.1300. Open 2.1100. Bid 2.0500 x 100. Ask 2.1100 x 200. Day's Range 2.0813 - 2.1900. 52 Week Range 1.4000 - 18.0000. Volume...HANOVER, MD - Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company, has announced a reverse stock split with a ratio of 1-for-20, set to take effect at market open ... scan qr code What's Happening With PCSA Stock Today? Processa Pharmaceuticals Inc (PCSA) stock is unchanged 0% while the S&P 500 has risen 0.7% as of 4:00 PM on Friday, Oct 13. PCSA is unchanged $0.00 from the previous closing price of $0.48 on volume of 19,953,405 shares. Over the past year the S&P 500 has risen 18.49% while PCSA has fallen -76.24%. Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. charlotte to london Interactive Chart. Interactive Charts provide the most advanced and flexible platform for analyzing historical data, with over 100 customizable studies, drawing tools, custom spreads and expressions, plus a wide range of visualization tools. While logged into the site, you will see continuous streaming updates to the chart. www aol com aol mail login 免费的Processa Pharmaceuticals (PCSA)分析工具，包括分析师评级、目标价预测，帮助您做出明智的投资决策.PCSA Earnings Date and Information. Processa Pharmaceuticals last posted its earnings data on March 29th, 2024. The reported ($0.24) EPS for the quarter. Processa … san francisco to phoenix Like other stocks, PCSA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Processa Pharmaceuticals, Inc. stock right from TradingView charts — choose …The PCSA shares have gain 17.97% over the last week, with a monthly amount glided 20.26%, and seem to be Processa Pharmaceuticals Inc [PCSA] stock prices are up 20.26% to $2.79 at the moment. It is a good measure of the stock's recent performance to check whether the stock's short-term value is rising or falling.Find the latest Processa Pharmaceuticals, Inc. (PCSA) stock quote, history, news and other vital information to help you with your stock trading and investing.